Procedure
Corneal sampling
Total Trials
2
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Ph phase_4
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(2)
Detailed Status
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
withdrawn150%
terminated150%
Recent Activity
Clinical Trials (2)
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 2